Research paper| Volume 14, ISSUE 1, P76-84, January 1997

Prophylactic efficacy of traditional herbal medicines against recurrent herpes simplex virus type 1 infection from latently infected ganglia in mice

      This paper is only available as a PDF. To read, Please Download here.


      Traditional herbal medicines with anti-herpes simplex virus type 1 (HSV-1) activity in vivo were examined for their prophylactic effects on recurrent HSV-1 infection in mice. Mice were intradermally infected with HSV-1 in the pinna and recurrent HSV-1 disease was induced by ultraviolet irradiation. Herbal extracts arrested the progression of recurrent HSV-1 disease, reduced the incidence of severe erythema and/or vesicles in the pinna, and/or shortened the period of severe recurrent lesions compared with water-administered mice (P < 0.01 or 0.05). Similarly, the prophylactic treatment of herbal extracts limited the development of recurrent skin lesions induced by stripping with cellophane tape physically. The prophylactic efficacy on recurrence was confirmed by the absence of HSV DNA in the skin lesions. HSV-1 genome was revealed to exist in the trigeminal ganglia but not in the pinna of latently infected mice before stimuli by a nested-polymerase chain reaction assay. After stimuli, HSV-1 genome was detected in both pinna and trigeminal ganglia of latently infected mice administered with water. However, prophylactic treatment decreased the rate of detection of HSV-1 genome in the stimulated pinna. Thus, the herbal extracts exhibited prophylactic efficacy against recurrent HSV-1 disease in mice and modulated the recurrent HSV-1 infection.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meyers JD
        • Flournoy N
        • Thomas ED
        Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.
        J Infect Dis. 1980; 142: 338-346
        • Pass RF
        • Whitley RJ
        • Whelchel JD
        • Diethelm AG
        • Reynolds DW
        • Alford CA
        Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation.
        J Infect Dis. 1979; 140: 487-492
        • Rand KH
        • Rasmussen LE
        • Pollard RB
        • Arvin A
        • Merigan TC
        Cellular immunity and herpesvirus infections in cardiac transplant patients.
        N Engl J Med. 1977; 296: 1372-1377
        • Saral R
        • Burns WH
        • Laskin OL
        • Santos GW
        • Lietman PS
        Acyclovir prophylaxis of herpes simplex virus infections.
        N Engl J Med. 1981; 305: 63-67
        • Spruance SL
        • Freeman DJ
        Topical treatment of cutaneous herpes simplex virus infections.
        Antiviral Res. 1990; 14: 305-321
        • Spruance SL
        • Schnipper LE
        • Overall Jr, JC
        Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol.
        J Infect Dis. 1982; 146: 85-90
        • Kurokawa M
        • Ochiai H
        • Nagasaka K
        • Neki M
        • Xu H
        • Kadota S
        • Sutardjo S
        • Matsumoto T
        • Namba T
        • Shiraki K
        Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice.
        Antiviral Res. 1993; 22: 175-188
        • Kurokawa M
        • Nagasaka K
        • Hirabayashi T
        • Uyama S
        • Sato H
        • Kageyama T
        • Kadota S
        • Ohyama H
        • Hozumi T
        • Namba T
        • Shiraki K
        Efficacy of traditional herb medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo.
        Antiviral Res. 1995; 27: 19-37
        • Kurokawa M
        • Sato H
        • Ohyama H
        • Hozumi T
        • Namba T
        • Kawana T
        • Shiraki K
        Effects of traditional herb medicines against herpes simplex virus (HSV) type 2 and acyclovir-resistant HSV type 1 in vitro and in vivo.
        J Traditional Med. 1995; 12: 187-194
        • Meyers JD
        • Wade JC
        • Mitchell CD
        • Saral R
        • Lietman PS
        • Durack DT
        • Levin MJ
        • Segreti AC
        • Balfour HH
        Multicenter collaborative trial of intraveneous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host.
        Am J Med. 1982; 73: 229-235
        • Whitley RJ
        • Alford CA
        • Hirsch MS
        • Schooley RT
        • Luby JP
        • Aoki FY
        • Hanley D
        • Nahmias AJ
        • Soong S-J
        • The NIAID Collaborative Antiviral Study Group
        Vidarabine versus acyclovir therapy in herpes simplex encephalitis.
        N Engl J Med. 1986; 314: 144-149
        • Whitley R
        • Arvin A
        • Prober C
        • Burchett S
        • Corey L
        • Powell D
        • Plotkin S
        • Starr S
        • Alford C
        • Connor J
        • Jacobs R
        • Nahmias A
        • Soong S-J
        • The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
        A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection.
        N Engl J Med. 1991; 324: 444-449
        • Jiangxu New Medical College
        Dictionary of Chinese Medicinal Materials. Shanghai Science and Technology Press, Shanghai, China1978 (in Chinese)
        • Kumano Y
        • Yamamoto M
        • Mori R
        Protection against herpes simplex virus infection in mice by recombinant murine interferon-b in combination with antibody.
        Antiviral Res. 1987; 7: 289-301
        • Shiraki K
        • Rapp F
        Effects of caffeine on herpes simplex virus.
        Intervirology. 1988; 29: 235-240
        • Hill TJ
        • Blyth WA
        • Harbour DA
        Trauma to the skin causes recurrence of herpes simplex in the mouse.
        J Gen Virol. 1978; 39: 21-28
        • Maniatis T
        • Fritsch EF
        • Sambrook J
        Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York1982
        • Kimura H
        • Shibata M
        • Kuzushima K
        • Nishikawa K
        • Nishiyama Y
        • Morishima T
        Detection and direct typing of herpes simplex virus by polymerase chain reaction.
        Med Microbiol Immunol. 1990; 179: 177-184
        • Gibbs JS
        • Chiou HC
        • Hall JD
        • Mount DW
        • Retondo MJ
        • Weller SK
        • Coen DM
        Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain.
        in: Proc Natl Acad Sci USA. 82. 1985: 7969-7973
        • Cook ML
        • Stevens JG
        Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.
        Infect Immunity. 1973; 7: 272-288
        • Klein RJ
        The pathogenesis of acute, latent and recurrent herpes simplex virus infections.
        Arch Virol. 1982; 72: 143-168
        • Penfold MET
        • Armati P
        • Cunningham AL
        Axonal transport of herpes simplex virions to epidermal cells: Evidence for a specialized mode of virus transport and assembly.
        in: Proc Natl Acad Sci USA. 91. 1994: 6529-6533
        • Kurokawa M
        • Ohyama H
        • Hozumi T
        • Namba T
        • Nakano M
        • Shiraki K
        Assay for antiviral activity of herbal extracts using their absorbed sera.
        Chem Pharm Bull. 1996; 44: 1270-1272